Response:

We would like to thank Dr White for valuable comments on our study that reported the first human β1-tubulin mutation associated with congenital macrothrombocytopenia.1  We have been working on congenital macrothrombocytopenia and analyzed more than 200 cases. We do not think that giant platelets from macrothrombocytopenia syndromes are necessarily larger than red blood cells. The mean platelet sizes determined as platelet diameters on peripheral blood smears in genetically confirmed Bernard-Soulier syndrome and MYH9 disorders2  were 5.3 (± 1.1) μm (n = 14) and 4.9 (± 1.1) μm (n = 81), respectively. These data are comparable with that of the patient in our study.1  Because routine automated blood cell counting systems differentiate blood cells by their size and therefore do not recognize giant platelets as platelets, mean platelet volume (MPV) does not reflect actual platelet size. As is quite often the case, an automated counter did not generate MPV in the patient or the mother. We believe that the determination of platelet diameter on peripheral smear is a more reliable way to detect macrothrombocytopenia.

Table 1

Clinical and laboratory parameters of 3 generations of family members carrying C326S ferroportin mutation

PatientIAIIAIIBIICIIIAIIIBIIIC
Age at diagnosis/sex 35/M 16/F 16/M 16/M 8/F 10/F 10/F 
Transferrin sat, initial  97%* 86%* 94%* 89%* 84%* 97%* 
Transferrin sat, current 79%* 89%* 70%* 89%* 93%* 91%* 51%* 
S-ferritin current, ng/mL 69 99 81 394* 114 21 11 
S-hepcidin, ng/mL 278* 198 297* 459* 453* 396* 13 
U-hepcidin, ng/mg creat 1308 2743* 2270* 3183* 3463* 3036* 72 
Liver biopsy Cirrhosis ↑ hepatocyte iron ↑ hepatocyte iron     
Clinical Arthritis, hip replacement mild arthritis mild arthritis mild LFT changes    
PatientIAIIAIIBIICIIIAIIIBIIIC
Age at diagnosis/sex 35/M 16/F 16/M 16/M 8/F 10/F 10/F 
Transferrin sat, initial  97%* 86%* 94%* 89%* 84%* 97%* 
Transferrin sat, current 79%* 89%* 70%* 89%* 93%* 91%* 51%* 
S-ferritin current, ng/mL 69 99 81 394* 114 21 11 
S-hepcidin, ng/mL 278* 198 297* 459* 453* 396* 13 
U-hepcidin, ng/mg creat 1308 2743* 2270* 3183* 3463* 3036* 72 
Liver biopsy Cirrhosis ↑ hepatocyte iron ↑ hepatocyte iron     
Clinical Arthritis, hip replacement mild arthritis mild arthritis mild LFT changes    

Normal serum hepcidin median (5%-95% range) was 112 ng/mL (29-254 ng/mL) for men, and 65 ng/mL (17-286 ng/mL) for women. Normal urine hepcidin median (full range) was 502 ng/mg creatinine (71-1762 ng/mg creatinine). M indicates male; F, female; sat, saturation; and creat, creatinine.

*

Above-normal values.

Below-normal values.

We admit that it is premature to make definite conclusions about how W318 β1-tubulin affects the normal platelet production and results in macrothrombocytopenia. This is mainly because the causative relationship between the mutation and giant platelets was not convincingly investigated in our work. To clarify this, we are planning to establish knockin cell models that equally express wild-type and mutant β1-tubulins identified in human1  and canine3  macrothrombocytopenia.

Conflict-of-interest disclosure: The authors declare no competing financial interests.

Correspondence: Shinji Kunishima, PhD, Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, 4-1-1 Sannomaru, Naka-ku, Nagoya 4600001, Japan; e-mail: [email protected].

1
Kunishima
 
S
Kobayashi
 
R
Itoh
 
TJ
Hamaguchi
 
M
Saito
 
H
Mutation of the β1-tubulin gene associated with congenital macrothrombocytopenia affecting microtubule assembly.
Blood
2009
, vol. 
113
 (pg. 
458
-
461
)
2
Kunishima
 
S
Yoshinari
 
M
Nishio
 
H
et al. 
Haematological characteristics of MYH9 disorders due to MYH9 R702 mutations.
Eur J Haematol
2007
, vol. 
78
 (pg. 
220
-
226
)
3
Davis
 
B
Toivio-Kinnucan
 
M
Schuller
 
S
Boudreaux
 
MK
Mutation in β1-tubulin correlates with macrothrombocytopenia in Cavalier King Charles spaniels.
J Vet Intern Med
2008
, vol. 
22
 (pg. 
540
-
545
)
Sign in via your Institution